2. Academic Validation
  3. Direct targeting and regulation of RNA polymerase II by cell signaling kinases

Direct targeting and regulation of RNA polymerase II by cell signaling kinases

  • Science. 2025 Nov 6;390(6773):eads7152. doi: 10.1126/science.ads7152.
Preeti Dabas 1,  Meritxell B Cutrona # 1,  Wojciech Rosikiewicz # 2,  Ryan P Kempen 1,  Patrick Rodrigues 3,  John Bowling 1,  Mollie S Prater 4,  Walter H Lang 1,  Adithi Danda 1,  Zhi Yuan 1,  Beisi Xu 2,  Shondra M Pruett-Miller 4,  Gang Wu 2,  Taosheng Chen 1,  Aseem Z Ansari 1
Affiliations

Affiliations

  • 1 Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • 2 Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • 3 Hartwell Center, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • 4 Center for Advanced Genomic Engineering, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • # Contributed equally.
PMID: 41197002 DOI: 10.1126/science.ads7152
Abstract

Distinct phosphorylation marks are placed on the carboxyl-terminal domain (CTD) of RNA polymerase II (Pol II) during different stages of gene transcription. These phospho-CTD marks function as a molecular recognition code for the recruitment of stage-specific effector proteins. Querying ~80% of the human kinome, we identified 117 kinases that phosphorylate the CTD with a high degree of positional selectivity. The unifying characteristic linking these diverse kinases is that they selectively regulate Pol II at signal-responsive genes. An example of such "direct-at-gene" Pol II regulation is displayed by epidermal growth factor receptor (EGFR), a cell surface receptor tyrosine kinase. More broadly, our atlas of CTD kinases implicates Pol II as a direct regulatory end point for signal-transducing kinases that govern cellular physiology and contribute to the etiology of numerous diseases.

Figures
Products